SOLID CANCERS
Clinical trials for SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCERS trials appear
Sign up with your email to follow new studies for SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug JY016 targets EGFR-Positive cancers in early trial
Disease control Not yet recruitingThis study tests a new drug called JY016 in people with advanced solid tumors that have a protein called EGFR. The goal is to find a safe dose and see if the drug can shrink tumors. The trial includes people with several cancer types, such as pancreatic, lung, and colorectal canc…
Matched conditions: SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Biotech Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to predict dangerous immunotherapy side effects before they happen
Knowledge-focused Not yet recruitingThis study will collect blood and swab samples from 160 adults with solid tumors who are about to start immunotherapy. The goal is to find a biological 'signature' that can predict which patients will develop severe immune-related side effects. If such a signature is found, it co…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
600 cancer patients to help unlock secrets of immunotherapy success
Knowledge-focused Not yet recruitingThis study will follow 600 people with early-stage solid cancers (like lung, head and neck, melanoma, or bladder cancer) who are receiving immunotherapy before surgery. Researchers will collect blood and tumor samples at several time points to see how the immune system responds. …
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC